{
    "nctId": "NCT01391689",
    "briefTitle": "Diindolylmethane in Treating Patients With Breast Cancer",
    "officialTitle": "Evaluation of Diindolylmethane Supplementation to Modulate Tamoxifen Efficacy in Breast Cancer The Diindolylmethane Efficacy Study",
    "overallStatus": "COMPLETED",
    "conditions": "Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 144,
    "primaryOutcomeMeasure": "Urinary 2OHE1:16alpha OHE1 ratio",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Prescribed TAM as adjuvant therapy for early stage (0, I, II, IIIa) breast cancer or as chemoprevention in women at high risk for breast cancer\n* New or planned prescription of TAM therapy; ineligible for randomization until on TAM for \\> 3 months with the expectation to continue use for \\> 18 months\n* Mammogram with Breast Imaging Reporting and Data System (BIRADS) score of \\>= 2; (equivalent to the following and similar breast density descriptive terms found in mammogram reports: 2 = scattered fibroglandular elements/densities; 3 = heterogeneously dense tissue; 4 = extremely dense tissue)\n* No use of soy-based dietary supplements or willingness to discontinue use, complete a 4-week wash-out period, prior to randomization, and refrain from use during trial period\n* If pre-menopausal, non-pregnant (confirmed with urinary pregnancy test); practicing birth control or s/p oophorectomy\n* Able to complete study run-in activities, including taking study-provided placebo pill twice daily (AM \\& PM) and recording pill intake and any symptoms experienced on a study calendar, with a compliance rate of at least 80%\n* Normal blood chemistry test that includes sodium and specific kidney and liver function tests (creatinine, alanine amino transferase-ALT, aspartate amino transferase-AST) within 30 days of study enrollment; (Informed Consent Form signed)\n* No history of hyponatremia",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}